These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36528013)

  • 1. Generation of two iPSC lines from long QT syndrome patients carrying SNTA1 variants.
    Jimenez-Tellez N; Vera CD; Yildirim Z; Vicente Guevara J; Zhang T; Wu JC
    Stem Cell Res; 2023 Feb; 66():103003. PubMed ID: 36528013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of an induced pluripotent stem cell line from a long QT syndrome patient carrying KCNH2/1956C > A mutation.
    Guo F; Sun Y; Wang H; Wang H; Zhou J; Fan H; Su J; Gong T; Jiang C; Liang P
    Stem Cell Res; 2022 Jul; 62():102813. PubMed ID: 35569348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha-1-syntrophin mutation and the long-QT syndrome: a disease of sodium channel disruption.
    Wu G; Ai T; Kim JJ; Mohapatra B; Xi Y; Li Z; Abbasi S; Purevjav E; Samani K; Ackerman MJ; Qi M; Moss AJ; Shimizu W; Towbin JA; Cheng J; Vatta M
    Circ Arrhythm Electrophysiol; 2008 Aug; 1(3):193-201. PubMed ID: 19684871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of three heterozygous KCNH2 mutation-carrying human induced pluripotent stem cell lines for modeling LQT2 syndrome.
    Mondéjar-Parreño G; Jahng JWS; Belbachir N; Wu BC; Zhang X; Perez MV; Badhwar N; Wu JC
    Stem Cell Res; 2021 Jul; 54():102402. PubMed ID: 34051449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of induced pluripotent stem cell lines from patients with LQT1 caused by heterozygous mutations in the KCNQ1 gene.
    Ren L; Jahng JWS; Belbachir N; Cook Z; Rivero GC; Perez MV; Wu JC
    Stem Cell Res; 2024 Aug; 78():103443. PubMed ID: 38763038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of patient-specific induced pluripotent stem cell lines with Type 2 Long QT Syndrome and the KCNH2 c.379C > T pathogenic variant.
    Goual L; Bounasri E; Vincenti M; Amédro P; Desprat R; Bernex F; Lemaitre JM; Pasquié JL; Lacampagne A; Thireau J; Meli AC
    Stem Cell Res; 2023 Oct; 72():103192. PubMed ID: 37660555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of eight human induced pluripotent stem cell (iPSC) lines from familial Long QT Syndrome type 1 (LQT1) patients carrying KCNQ1 c.1697C>A mutation (NUIGi005-A, NUIGi005-B, NUIGi005-C, NUIGi006-A, NUIGi006-B, NUIGi006-C, NUIGi007-A, and NUIGi007-B).
    Ge N; Liu M; Krawczyk J; McInerney V; Galvin J; Shen S; O'Brien T; Prendiville T
    Stem Cell Res; 2019 Aug; 39():101502. PubMed ID: 31415974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and characterization of an induced pluripotent stem cell (iPSC) line (NUIGi003-A) from a long QT syndrome type 2 (LQT2) patient harbouring the KCNH2 c.2464G>A pathogenic variant.
    Ge N; Liu M; Krawczyk J; McInerney V; Ward D; Shen S; O'Brien T; Prendiville T
    Stem Cell Res; 2020 Dec; 49():101997. PubMed ID: 33002718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling the long QT syndrome with induced pluripotent stem cells.
    Itzhaki I; Maizels L; Huber I; Zwi-Dantsis L; Caspi O; Winterstern A; Feldman O; Gepstein A; Arbel G; Hammerman H; Boulos M; Gepstein L
    Nature; 2011 Mar; 471(7337):225-9. PubMed ID: 21240260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of two iPSC lines from hypertrophic cardiomyopathy patients carrying MYBPC3 and PRKAG2 variants.
    Manhas A; Jahng JWS; Vera CD; Shenoy SP; Knowles JW; Wu JC
    Stem Cell Res; 2022 May; 61():102774. PubMed ID: 35413566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digenic inheritance novel mutations in SCN5a and SNTA1 increase late I(Na) contributing to LQT syndrome.
    Hu RM; Tan BH; Orland KM; Valdivia CR; Peterson A; Pu J; Makielski JC
    Am J Physiol Heart Circ Physiol; 2013 Apr; 304(7):H994-H1001. PubMed ID: 23376825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome sequencing in a genetically elusive multigenerational long QT syndrome pedigree identifies a novel LQT2-causative deeply intronic KCNH2 variant.
    Tobert KE; Tester DJ; Zhou W; Haglund-Turnquist CM; Giudicessi JR; Ackerman MJ
    Heart Rhythm; 2022 Jun; 19(6):998-1007. PubMed ID: 35144019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LQTS-associated mutation A257G in α1-syntrophin interacts with the intragenic variant P74L to modify its biophysical phenotype.
    Cheng J; Norstrand DW; Medeiros-Domingo A; Tester DJ; Valdivia CR; Tan BH; Vatta M; Makielski JC; Ackerman MJ
    Cardiogenetics; 2011 Oct; 1(1):. PubMed ID: 24319568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syntrophin mutation associated with long QT syndrome through activation of the nNOS-SCN5A macromolecular complex.
    Ueda K; Valdivia C; Medeiros-Domingo A; Tester DJ; Vatta M; Farrugia G; Ackerman MJ; Makielski JC
    Proc Natl Acad Sci U S A; 2008 Jul; 105(27):9355-60. PubMed ID: 18591664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic mechanism and gene correction for LQTS-causing double mutations in KCNQ1 using a pluripotent stem cell model.
    Wang Z; Wang L; Liu W; Hu D; Gao Y; Ge Q; Liu X; Li L; Wang Y; Wang S; Li C
    Stem Cell Res; 2019 Jul; 38():101483. PubMed ID: 31226583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of three induced pluripotent stem cell lines (SCVIi014-A, SCVIi015-A, and SCVIi016-A) from patients with LQT1 caused by heterozygous mutations in the KCNQ1 gene.
    Zhang H; Jahng JWS; Liu Y; Chase AJ; Perez MV; Wu JC
    Stem Cell Res; 2021 Aug; 55():102492. PubMed ID: 34411974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes.
    Lee YK; Sala L; Mura M; Rocchetti M; Pedrazzini M; Ran X; Mak TSH; Crotti L; Sham PC; Torre E; Zaza A; Schwartz PJ; Tse HF; Gnecchi M
    Cardiovasc Res; 2021 Feb; 117(3):767-779. PubMed ID: 32173736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human induced pluripotent stem cell line ZZUNEUi027-A generated from a long QT syndrome patient with a heterozygous KCNH2 (c. 128 A > G) mutant.
    Zhao J; Wang L; Zhu K; Chen X; Qin F; Li X; Dong J; Tao H
    Stem Cell Res; 2022 Aug; 63():102836. PubMed ID: 35700634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of two induced pluripotent stem cell (iPSC) lines (BBANTWi006-A, BBANTWi007-A) from Brugada syndrome patients carrying an SCN5A mutation.
    Simons E; Nijak A; Loeys B; Alaerts M
    Stem Cell Res; 2022 Apr; 60():102719. PubMed ID: 35247843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of patient-specific induced pluripotent stem cell lines from one patient with Jervell and Lange-Nielsen syndrome, one with type 1 long QT syndrome and two healthy relatives.
    Kasai-Brunswick TH; Silva Dos Santos D; Ferreira RP; Araujo DS; Dias GM; Coutinho JLA; Cruz FESF; Sternick EB; Gubert F; Oliveira JCG; Vaz IM; Borgonovo T; Brofman PRS; Moura-Neto RS; Silva R; Campos-de-Carvalho AC; Carvalho AB
    Stem Cell Res; 2018 Aug; 31():174-180. PubMed ID: 30099333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.